A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease

por Manka, Paul P., Kaya, Eda, Canbay, Ali, Syn, Wing-Kin
Publicado 2021

Non-Invasive Risk Stratification in NAFLD/NASH Patients for Screening EGD

por Romano, John, Abdelfattah, Thaer, Manka, Paul P, Fuchs, Michael, Syn, Wing-Kin
Publicado 2022

Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Leve...

por Schwertheim, Suzan, Alhardan, Malek, Manka, Paul P., Sowa, Jan-Peter, Canbay, Ali, Schmidt, Hartmut H.-J., Baba, Hideo A., Kälsch, Julia
Publicado 2023

LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis

por Leyh, Catherine, Heucke, Niklas, Schotten, Clemens, Büchter, Matthias, Bechmann, Lars P., Wichert, Marc, Dechêne, Alexander, Herrmann, Ken, Heider, Dominik, Sydor, Svenja, Lemmer, Peter, Ludwig, Johannes M., Pospiech, Josef, Theysohn, Jens, Damm, Robert, March, Christine, Powerski, Maciej, Pech, Maciej, Özcürümez, Mustafa, Weigt, Jochen, Keitel, Verena, Lange, Christian M., Schmidt, Hartmut, Canbay, Ali, Best, Jan, Gerken, Guido, Manka, Paul P.
Publicado 2022